|
1
|
Tenbrock K, Juang YT, Kyttaris VC and
Tsokos GC: Altered signal transduction in SLE T cells. Rheumatology
(Oxford). 46:1525–1530. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Saxena R, Mahajan T and Mohan C: Lupus
nephritis: Current update. Arthritis Res Ther.
13(240)2011.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Caltik A, Demircin G, Bulbul M, Erdogan O,
Akyuz SG and Arda N: An unusual case of ANA negative systemic lupus
erythematosus presented with vasculitis, long-standing serositis
and full-house nephropathy. Rheumatol Int. 33:219–222.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Appleman LJ and Boussiotis VA: T cell
anergy and costimulation. Immunol Rev. 192:161–180. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lenschow DJ, Walunas TL and Bluestone JA:
CD28/B7 system of T cell costimulation. Annu Rev Immunol.
14:233–258. 1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bretscher P and Cohn M: A theory of
self-nonself discrimination. Science. 169:1042–1049.
1970.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bour-Jordan H and Blueston JA: CD28
function: A balance of costimulatory and regulatory signals. J Clin
Immunol. 22:1–7. 2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Suvas S, Singh V, Sahdev S, Vohra H and
Agrewala JN: Distinct role of CD80 and CD86 in the regulation of
the activation of B cell and B cell lymphoma. J Biol Chem.
277:7766–7775. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Reynolds J, Tam FW, Chandraker A, Smith J,
Karkar AM, Cross J, Peach R, Sayegh MH and Pusey CD: CD28-B7
blockade prevents the development of experimental autoimmune
glomerulonephritis. J Clin Invest. 105:643–651. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Lewis RM, Armstrong MY, Andre-Schwartz J,
Muftuoglu A, Beldotti L and Schwartz RS: Chronic allogeneic
disease. I. Development of glomerulonephritis. J Exp Med.
128:653–679. 1968.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sekine H, Watanabe H and Gilkeson GS:
Enrichment of anti-glomerular antigen antibody-producing cells in
the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 172:3913–3921.
2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shi Q, Gao ZY, Xie F, Wang LF, Gu YP, Yang
TJ, Huang L, Qian QH and Qiu YH: A novel monoclonal antibody
against human CD80 and its immune protection in a mouse lupus-like
disease. Int J Immunopathol Pharmacol. 24:583–593. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang GB, Zhou H, Chen YJ, Ge Y, Xie F,
Shi Q, Ma HB, Fei M and Zhang XG: Characterization and application
of two novel monoclonal antibodies against 2IgB7-H3: Expression
analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue
Antigens. 66:83–92. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun WP, Wang FM, Xie F, Wang GQ, Sun J, Yu
GH, Qiu YH and Zhang XG: A novel anti-human syndecan-1 (CD138)
monoclonal antibody 4B3: Characterization and application. Cell Mol
Immunol. 4:209–214. 2007.PubMed/NCBI
|
|
15
|
Kints JP, Manouvriez P and Bazin H: Rat
monoclonal antibodies. VII. Enhancement of ascites production and
yield of monoclonal antibodies in rats following pretreatment with
pristane and Freund's adjuvant. J Immunol Methods. 119:241–245.
1989.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kronick MN: The use of phycobiliproteins
as fluorescent labels in immunoassay. J Immunol Methods. 92:1–13.
1986.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Han L, Shen L, Zhu Y and Qiu Y: A
monoclonal antibody against CD86 and its protection in a murine
lupus nephritis model of chronic graft-versus-host disease.
Immunopharmacol Immunotoxicol. 39:285–291. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bruns A, Blass S, Hausdorf G, Burmester GR
and Hiepe F: Nucleosomes are major T and B cell autoantigens in
systemic lupus erythematosus. Arthritis Rheum. 43:2307–2315.
2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Murphy WJ: Revisiting graft-versus-host
disease models of autoimmunity: New insights in immune regulatory
processes. J Clin Invest. 106:745–747. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Howie JB and Helyer BJ: The immunology and
pathology of NZB mice. Adv Immunol. 9:215–266. 1968.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ka SM, Rifai A, Chen JH, Cheng CW, Shui
HA, Lee HS, Lin YF, Hsu LF and Chen A: Glomerular crescent-related
biomarkers in a murine model of chronic graft versus host disease.
Nephrol Dial Transplant. 21:288–298. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Foster AD, Soloviova K, Puliaeva I,
Puliaiev M, Puliaev R, Finkelman F and Via CS: Donor CD8 T cells
and IFN-gamma are critical for sex-based differences in donor CD4 T
cell engraftment and lupus-like phenotype in short-term chronic
graft-versus-host disease mice. J Immunol. 186:6238–6254.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rus V, Svetic A, Nguyen P, Gause WC and
Via CS: Kinetics of Th1 and Th2 cytokine production during the
early course of acute and chronic murine graft-versus-host disease.
Regulatory role of donor CD8+ T cells. J Immunol. 155:2396–2406.
1995.PubMed/NCBI
|
|
24
|
Bergijk EC, Munaut C, Baelde JJ, Prins F,
Foidart JM, Hoedemaeker PJ and Bruijn JA: A histologic study of the
extracellular matrix during the development of glomerulosclerosis
in murine chronic graft-versus-host disease. Am J Pathol.
140:1147–1156. 1992.PubMed/NCBI
|
|
25
|
Dhaher YY, Chan K, Greenstein BD, de
Fougerolles Nunn E, Khamashta MA and Hughes GR: Impaired estrogen
priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice,
a model of systemic lupus erythematosus (SLE). Int J
Immunopharmacol. 22:537–545. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kuroda Y, Akaogi J, Nacionales DC, Wasdo
SC, Szabo NJ, Reeves WH and Satoh M: Distinctive patterns of
autoimmune response induced by different types of mineral oil.
Toxicol Sci. 78:222–228. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim J, Park K, Kim HJ, Kim J, Kim HA, Jung
D, Kim HJ, Choi HJ, Choi SY, Seo KW, et al: Breaking of CD8+ T cell
tolerance through in vivo ligation of CD40 results in inhibition of
chronic graft-versus-host disease and complete donor cell
engraftment. J Immunol. 181:7380–7389. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kothlow S, Morgenroth I, Tregaskes CA,
Kaspers B and Young JR: CD40 ligand supports the long-term
maintenance and differentiation of chicken B cells in culture. Dev
Comp Immunol. 32:1015–1026. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Leitner J, Grabmeier-Pfistershammer K and
Steinberger P: Receptors and ligands implicated in human T cell
costimulatory processes. Immunol Lett. 128:89–97. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nagafuchi H, Shimoyama Y, Kashiwakura J,
Takeno M, Sakane T and Suzuki N: Preferential expression of B7.2
(CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L
interaction is essential for anti-DNA autoantibody production in
patients with systemic lupus erythematosus. Clin Exp Rheumatol.
21:71–77. 2003.PubMed/NCBI
|
|
31
|
Bijl M, Horst G, Limburg PC and Kallenberg
CG: Expression of costimulatory molecules on peripheral blood
lymphocytes of patients with systemic lupus erythematosus. Ann
Rheum Dis. 60:523–526. 2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Folzenlogen D, Hofer MF, Leung DY, Freed
JH and Newell MK: Analysis of CD80 and CD86 expression on
peripheral blood B lymphocytes reveals increased expression of CD86
in lupus patients. Clin Immunol Immunopathol. 83:199–204.
1997.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Laurent L, Le Fur A, Le Bloas RL, Néel M,
Mary C, Moreau A, Poirier N, Vanhove B and Fakhouri F: Prevention
of lupus nephritis development in NZB/NZW mice by selective
blockade of CD28. Eur J Immunol. 47:1368–1376. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Asai T, Choi BK, Kwon PM, Kim WY, Kim JD,
Vinay DS, Gebhardt BM and Kwon BS: Blockade of the 4-1BB
(CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways
promotes corneal allograft survival in mice. Immunology.
121:349–358. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Blazar BR, Sharpe AH, Taylor PA,
Panoskaltsis-Mortari A, Gray GS, Korngold R and Vallera DA:
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal
antibodies inhibits murine graft-versus-host disease lethality in
part via direct effects on CD4+ and CD8+ T cells. J Immunol.
157:3250–3259. 1996.PubMed/NCBI
|
|
36
|
Brunner-Weinzierl MC, Hoff H and Burmester
GR: Multiple functions for CD28 and cytotoxic T lymphocyte
antigen-4 during different phases of T cell responses: Implications
for arthritis and autoimmune diseases. Arthritis Res Ther. 6:45–54.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Finck BK, Linsley PS and Wofsy D:
Treatment of murine lupus with CTLA-Ig. Science. 265:1225–1227.
1994.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Furie R, Nicholls K, Cheng TT, Houssiau F,
Burgos-Vargas R, Chen SL, Hillson JL, Meadows-Shropshire S,
Kinaszczuk M and Merrill JT: Efficacy and safety of abatacept in
lupus nephritis: A twelve-month, randomized, double-blind study.
Arthritis Rheumatol. 66:379–389. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Danion F, Rosine N, Belkhir R, Gottenberg
JE, Hachulla E, Chatelus E, Pugnet G, Pers YM, Mariette X, Sibilia
J, et al: Efficacy of abatacept in systemic lupus erythematosus: A
retrospective analysis of 11 patients with refractory disease.
Lupus. 25:1440–1447. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Cunnane G, Chan OT, Cassafer G, Brindis S,
Kaufman E, Yen TSB and Daikh DI: Prevention of renal damage in
murine lupus nephritis by CTLA-4Ig and cyclophosphamide. Arthritis
Rheum. 50:1539–1548. 2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Freeman GJ, Gray GS, Gimmi CD, Lombard DB,
Zhou LJ, White M, Fingeroth JD, Gribben JG and Nadler LM:
Structure, expression, and T cell costimulatory activity of the
murine homologue of the human B lymphocyte activation antigen B7. J
Exp Med. 174:625–631. 1991.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tieng AT and Peeva E: B-cell-directed
therapies in systemic lupus erythematosus. Semin Arthritis Rheum.
38:218–227. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mills JA: Systemic lupus erythematosus. N
Engl J Med. 330:1871–1879. 1994.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Satoh M, Kumar A, Kanwar YS and Reeves WH:
Anti-nuclear antibody production and immune-complex
glomerulonephritis in BALB/c mice treated with pristane. Proc Natl
Acad Sci USA. 92:10934–10938. 1995.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Nagata M, Ninomiya T, Kiyohara Y, Murakami
Y, Irie F, Sairenchi T, Miura K, Okamura T and Ueshima H:
EPOCH-JAPAN Research Group. Prediction of cardiovascular disease
mortality by proteinuria and reduced kidney function: Pooled
analysis of 39,000 individuals from 7 cohort studies in Japan. Am J
Epidemiol. 178:1–11. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Currie G and Delles C: Proteinuria and its
relation to cardiovascular disease. Int J Nephrol Renovasc Dis.
7:13–24. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Holdsworth SR, Gan PY and Kitching AR:
Biologics for the treatment of autoimmune renal diseases. Nat Rev
Nephrol. 12:217–231. 2016.PubMed/NCBI View Article : Google Scholar
|
